Stockreport

Epsilogen Announces Initiation of Phase Ib Trial of MOv18 IgE [Yahoo! Finance]

FTI Consulting, Inc.  (FCN) 
Last fti consulting, inc. earnings: 4/30 07:30 am Check Earnings Report
US:NYSE Investor Relations: ir.fticonsulting.com
PDF LONDON, December 03, 2024 BUSINESS WIRE )--Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that it [Read more]